Postoperative Radiotherapy &#xb1; Cetuximab for Intermediate-Risk Head and Neck Cancer

Head and Neck Cancer

Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: Head and Neck Cancer International Group consensus recommendations

Lancet Oncol

Abou-Foul AK, Henson C, Chernock RD, Huang SH, Lydiatt WM, McDowell L, O'Sullivan B, Perez-Ordonez B, Robinson M, Nankivell PC, Ruiz-Bravo E, Chiosea SI, Green TM, Hunter KD, Hwang JS, Koljenovic S, Koppes SA, Larsen SR, Lo AWI, Costes-Martineau V, Mittal N, Mori T, Nagao T, Panayiotides IG, Pinto CAL, Scheckenbach K, Seethala RR, Ulhøi BP, Vingiani A, Zhang Y, Yom SS, Mehanna H

doi: 10.1016/S1470-2045(24)00143-8

Breast Cancer

Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer

J Natl Cancer Inst

Palmér S, Valachis A, Lindman H, Smith DR, Wickberg Å, Killander F, Bjöhle J, Einbeigi Z, Nilsson G, Ahlgren J, Villman K

doi: 10.1093/jnci/djae315

ASCO 2024

Head and Neck Cancer

HPV vaccine can reduce the risk of HPV-related head and neck cancers in men

Head and Neck Cancer

Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based Model

J Clin Oncol

Watson E EE, Hueniken K, Lee J, Huang SH, El Maghrabi A, Xu W, Moreno AC, Tsai CJ, Hahn E, McPartlin AJ, Yao CMKL, Goldstein DP, De Almeida JR, Waldon JN, Fuller CD, Hope AJ, Ruggiero SL, Glogauer M, Hosni AA

doi: 10.1200/JCO.23.01951

Head and Neck Cancer

Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendations

Lancet Oncol

Lim AM, Le Tourneau C, Hurt C, Laskar SG, Steuer CE, Chow VLY, Szturz P, Henson C, Day AT, Bates JE, Lazarakis S, McDowell L, Mehanna H, Yom SS, HNCIG

doi: 10.1016/S1470-2045(24)00068-8

Head and Neck Cancer

Chronotherapy in head and neck cancer: A systematic review and meta-analysis

Int J Cancer

Abusamak M, Abu-Samak AA, Cai W, Al-Waeli H, Al-Hamed FS, Al-Tamimi M, Juweid M, Chaurasia A, Nicolau B, Tamimi F

doi: 10.1002/ijc.35234

Head and Neck Cancer

Management of head and neck cancer of unknown primary: A phase IV study by DAHANCA

Eur J Cancer

Nielsen SB, Lyhne NM, Andersen M, Plaschke CC, Gothelf AB, Johansen J, Maare C, Farhadi M, Godballe C, Primdahl H, Holm AIS, Alsner J, Kjærgaard T, Overgaard J

doi: 10.1016/j.ejca.2024.115211

Genitourinary Cancer

Head-to-head comparison of GA-68 PSMA PET/CT and multiparametric MRI findings with postoperative results in preoperative locoregional staging and localization of prostate cancer

Prostate

Dinckal M, Ergun KE, Kalemci MS, Guler E, Tokac R, Ordu S, Ogut N, Ozgul S, Sanli O, Sen S, Turna B

doi: 10.1002/pros.24799

Genitourinary Cancer

A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer

Cancer Epidemiol Biomarkers Prev

Farazi M, Yang X, Gehl CJ, Barnett GC, Burnet NG, Chang-Claude J, Parker CC, Dunning AM, Azria D, Choudhury A, Rancati T, De Ruysscher D, Seibold P, Sperk E, Talbot CJ, Veldeman L, Webb AJ, Elliott R, Aguado-Barrera ME, Carballo AM, Fuentes-Ríos O, Gómez-Caamaño A, Peleteiro P, Vega A, Ostrer H, Rosenstein BS, Saito S, Parliament M, Usmani N, Marples B, Chen Y, Morrow G, Messing E, Janelsins MC, Hall W, West CML, Auer PL, Kerns S

doi: 10.1158/1055-9965.EPI-24-1228

Oncology · Hematology

Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer

Related content

Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: Head and Neck Cancer International Group consensus recommendations

Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer

HPV vaccine can reduce the risk of HPV-related head and neck cancers in men

Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based Model

Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendations

Chronotherapy in head and neck cancer: A systematic review and meta-analysis

Management of head and neck cancer of unknown primary: A phase IV study by DAHANCA

Head-to-head comparison of GA-68 PSMA PET/CT and multiparametric MRI findings with postoperative results in preoperative locoregional staging and localization of prostate cancer

A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer